Abstract:Ebselen (EBS) is an organo-selenium-containing compound that has anti-inflammatory, antitumor, and antibacterial properties. EBS is being explored as a possible treatment for reperfusion injury and stroke and is under clinical trials as a mimetic of lithium for the treatment of bipolar disorder [Motaet al. Synapse 2020, 74 (7), 1−6] and noise-induced hearing loss as a result of these actives [Martini et al. J. Psychiatr. Res. 2019, 109, 107−117. Slusarczyket al. Neural Regener. Res. 2019, 17 (7), 1255–1261. Thangamaniet al. PLoS One 2015, 10 (7), e0133877. Kil et al. Lancet 2017, 390 (10098), 969–979]. However, we wanted to characterize derivatives of EBS as neuroprotective, anti-neuroinflammatory, and antioxidant compounds. Recently, we have reported on a new thermal and photoinduced copper-mediated cross-coupling between potassium selenocyanate (KSeCN) and N-substituted ortho-halobenzamides to form ebselen derivatives with increased synthetic efficiency [Thanna et al. J. Org. Chem. 2017, 82 (7), 3844−3854]. Our synthesis allows for the varying of the remote benzene ring with various substituents or replacing that ring with heterocyclic rings such as pyridine, pyrrole, thiophene, etc. In this study, we synthesized seven new heterocyclic EBS derivatives to further diversify our EBS library. These 21 compounds were then evaluated for their neuroprotective properties, with four compounds showing an equal or better neuroprotective profile than EBS. Compounds 5, 9, 23, and 27 showed 73, 86, 80, 84% cell viability, respectively, at a 10 μM concentration. These studies were performed using human neuroblastoma SH-SY5Y cells in an oxygen and glucose deprivation (OGD) model of ischemia. At the same concentration, these compounds significantly inhibited lipopolysaccharide-induced nitric oxide and tumor necrosis factor alpha release from Human microglia clone 3 microglial cells. Compounds 9 and 27 showed significantly increased cell viability (84 and 80%, respectively) for SH-SY5Y cells exposed to microglia-activated media. These compounds showed only mild GPx-like reductive activity, with compounds 2, 7, 12, and 14 (115, 96, 95, and 82%, respectively) showing a higher percent rate of oxidation of NADPH in a coupled reaction assay compared to ebselen. This research highlights several derivatives of ebselen that show improved activity as neuroprotective agents over the parent compound.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschemneuro.0c00328?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschemneuro.0c00328</a>.Supporting information include 1H NMR spectra, 13C NMR spectra of compounds 15a–21a and 15–21, and further experimental details (<a class="ext-link" href="/doi/suppl/10.1021/acschemneuro.0c00328/suppl_file/cn0c00328_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Chalcogen bonding interaction between ebselen and nitrite promote N-nitrosation of amines

Structurally Innovative Benzimidazole‐fused Ionic Organoselenium Compounds: Prevalence of Se···N/Se Chalcogen Bonds with the Selenocyanate Receptor

Synthesis, Antioxidant and Structural Properties of Modified Ebselen Derivatives and Conjugates

Copper-Catalyzed N-H Bond Chalcogenation of Anilines

Fingerprints of Chalcogen Bonding Revealed Through 77Se-NMR

Fingerprints of Chalcogen Bonding Revealed Through 77Se‐NMR

Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration

Electrostatic Surface Potentials and Chalcogen-Bonding Motifs of Substituted 2,1,3-Benzoselenadiazoles Probed via 77Se Solid-State NMR Spectroscopy

Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation

Role of Ancillary Ligands in S -nitrosothiol and NO Generation from Nitrite-Thiol Interactions at Mononuclear Zinc(II) Sites

Elucidating the Binding Mode of Sulfur‐ and Selenium‐Based Cationic Chalcogen‐Bond Donors

Novel Fe (III), Cu (II), and Zn (II) Chelates of Organoselenium‐Based Schiff Base: Design, Synthesis, Characterization, DFT, Anticancer, Antimicrobial, and Antioxidant Investigations

EDA mediated S–N bond coupling of nitroarenes and sodium sulfinate salts

Gold‐promoted biocompatible selenium arylation of small molecules, peptides and proteins

Visible-light-promoted denitrogenative ortho -selenylation reaction of benzotriazinones: synthesis of ortho -selenylated benzamides and ebselen analogs

Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

Nitrate reductase involves in selenite reduction in Rahnella aquatilis HX2 and the characterization and anticancer activity of the biogenic selenium nanoparticles

Peroxodisulfate-Mediated Selenoamination Of Alkenes Yielding Amidoselenide-Containing Sulfamides And Azoles

Synthesis of bis‐Naphthol based Organoselenium Antioxidants as Efficient Inhibitors against Biofilms

Asymmetric N -oxidation catalyzed by bisguanidinium dinuclear oxodiperoxomolybdosulfate

Intermediates Regulation via Electron‐deficient Cu Sites for Selective Nitrate‐to‐Ammonia Electroreduction